Economics of antibiotic use policies.
Today more than ever, hospitals must effectively manage the use of antibiotics to control costs and preserve their usefulness. To achieve this goal, antibiotic management must evolve from overly simplistic antibiotic cost containment to more complex, multidisciplinary, appropriate use programs that are founded on clinical outcomes-based pharmacoeconomic analyses. This article addresses common cost-containment activities as they relate to antibiotics and examines their consequences. Examples of successful antimicrobial stewardship and the role of pharmacoeconomic analyses also are provided. Cost-effectiveness studies of cefepime are presented to illustrate the utility of these analyses and provide information that can form the basis for decisions regarding placement of cefepime on hospital formularies.
Paladino
Joseph A
JA
State University of New York at Buffalo, and Clinical Outcomes and Pharmacoeconomics, CPL Associates LLC, Buffalo, New York 14226-1727, USA. paladino@cplassociates.com
D000900:Anti-Bacterial Agents / Q000191:economics* / Q000627:therapeutic use; D003363:Cost Control / Q000191:economics / Q000379:methods; D017048:Health Care Costs; D006801:Humans
D000900:Anti-Bacterial Agents